| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/15/2011 | CA2529452C Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis |
| 02/15/2011 | CA2501651C Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| 02/15/2011 | CA2499620C External preparation containing acetylsalicylic acid for inhibiting keloid formation |
| 02/15/2011 | CA2496842C Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/15/2011 | CA2491172C Microcapsules for the delayed, controlled release of perindopril |
| 02/15/2011 | CA2483594C Use of edg receptor binding agents in cancer |
| 02/15/2011 | CA2481460C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 02/15/2011 | CA2480872C Amino acids with affinity for the .alpha.-2-.delta.-protein |
| 02/15/2011 | CA2480562C 5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 02/15/2011 | CA2480560C .kappa.-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2476996C Methods for preventing or treating cardiac arrhythmia |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2465043C Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| 02/15/2011 | CA2461572C Polycyclic compounds having anti-tumor activity |
| 02/15/2011 | CA2461348C [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 02/15/2011 | CA2460340C Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
| 02/15/2011 | CA2459724C Multi-use multimodal imaging chelates |
| 02/15/2011 | CA2458856C Improved therapeutic protocols |
| 02/15/2011 | CA2457671C Process for the preparation of a 14-hydroxynormorphinone derivative |
| 02/15/2011 | CA2457212C Glycine-substituted thieno [2,3-d]pyrimidines with combined lh and fsh agonistic activity |
| 02/15/2011 | CA2456411C Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 02/15/2011 | CA2455453C Taxol enhancer compounds |
| 02/15/2011 | CA2453254C Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia |
| 02/15/2011 | CA2453013C Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
| 02/15/2011 | CA2452502C 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2451043C Enhanced drug delivery in transdermal systems |
| 02/15/2011 | CA2450890C Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram |
| 02/15/2011 | CA2450213C Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
| 02/15/2011 | CA2446864C Inhibitors of src and other protein kinases |
| 02/15/2011 | CA2444895C Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/15/2011 | CA2433071C Use of transcription factor yb-1 in adenoviral systems |
| 02/15/2011 | CA2432177C Drug for prevention and/or therapy of endometriosis |
| 02/15/2011 | CA2416757C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 02/15/2011 | CA2407027C Improved water-insoluble drug particle process |
| 02/15/2011 | CA2406930C Preparation of aqueous clear solution dosage forms with bile acids |
| 02/15/2011 | CA2402449C Pharmaceutical compositions including alginates |
| 02/15/2011 | CA2377085C Substituted benzimidazoles |
| 02/15/2011 | CA2373554C Process for the preparation and purification of thiol-containing maytansinoids |
| 02/15/2011 | CA2353544C Preparation that contains oligosaccharides and probiotics |
| 02/15/2011 | CA2352765C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/15/2011 | CA2334863C Antithrombotic compounds |
| 02/15/2011 | CA2247420C Combination therapy for osteoporosis |
| 02/15/2011 | CA2233961C Stimulation of hair follicles |
| 02/15/2011 | CA2196304C Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 02/13/2011 | CA2804265A1 Methods and compositions for treating thyroid-related medical conditions with reduced folates |
| 02/11/2011 | WO2011018793A1 A novel standardized composition, method of manufacture and use in the resolution of rna virus infection |
| 02/11/2011 | CA2807557A1 Diagnosis of primary and metastatic basal-like breast cancer and other cancer types |
| 02/11/2011 | CA2721040A1 Procyanidin extracts of cinnamon, litchi and arachis useful in the treatment of retroviral infections |
| 02/10/2011 | WO2011017697A1 Compositions and methods for treating inflammatory disorders |
| 02/10/2011 | WO2011017639A1 Methods of using c-met modulators |
| 02/10/2011 | WO2011017634A2 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| 02/10/2011 | WO2011017612A1 Substituted diphenylpyrazine derivatives |
| 02/10/2011 | WO2011017611A1 Lipidated oxoadenine derivatives |
| 02/10/2011 | WO2011017600A2 Compositions and methods for treating beta-amyloid related diseases |
| 02/10/2011 | WO2011017578A1 Sphingosine-1-phosphate receptor agonists |
| 02/10/2011 | WO2011017564A2 Identification and use of compounds for treating persistent pain |
| 02/10/2011 | WO2011017554A2 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 02/10/2011 | WO2011017534A2 Treatment of prostate cancer |
| 02/10/2011 | WO2011017520A1 Compositions and methods for inducing apoptosis in prostate cancer cells |
| 02/10/2011 | WO2011017519A2 Inhibitors of methionine aminopeptidases and methods of treating disorders |
| 02/10/2011 | WO2011017516A2 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
| 02/10/2011 | WO2011017500A1 Amphiphilic janus-dendrimers |
| 02/10/2011 | WO2011017488A2 Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity |
| 02/10/2011 | WO2011017484A2 Sublingual and buccal film compositions |
| 02/10/2011 | WO2011017483A2 Sublingual and buccal film compositions |
| 02/10/2011 | WO2011017456A2 Localized delivery of nanoparticles for therapeutic and diagnostic applications |
| 02/10/2011 | WO2011017404A2 Retroelements and mental disorders and methods of measuring l1 retrotransposition |
| 02/10/2011 | WO2011017395A1 Chemical compounds |
| 02/10/2011 | WO2011017389A1 Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv |
| 02/10/2011 | WO2011017380A1 Therapeutic vitamin d sun-protecting formulations and methods for their use |
| 02/10/2011 | WO2011017350A2 Compounds as lysophosphatidic acid receptor antagonists |
| 02/10/2011 | WO2011017346A2 Fast-acting naproxen composition with reduced gastrointestinal effects |
| 02/10/2011 | WO2011017319A1 Methods of treating disorders associated with protein polymerization |
| 02/10/2011 | WO2011017299A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE |
| 02/10/2011 | WO2011017296A1 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors |
| 02/10/2011 | WO2011017244A1 Polymorphs of 5-(4-(2-(5-ethylpyridin-2-yl)-2-oxoethoxy)benzyl)-1,3-thiazolidine-2,4-dione (mitoglitazone) |
| 02/10/2011 | WO2011017219A1 Imidazoquinoxalinones and anti-tumor treatment |
| 02/10/2011 | WO2011017201A2 Dp2 antagonist and uses thereof |
| 02/10/2011 | WO2011017195A2 Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith |
| 02/10/2011 | WO2011017178A1 Compositions and methods for inhibition of the jak pathway |
| 02/10/2011 | WO2011017165A1 Method of preventing renal disease and treating symptoms thereof |
| 02/10/2011 | WO2011017162A2 Methods for enhancing antigen-specific immune responses |
| 02/10/2011 | WO2011017142A1 Novel bicyclic urea compounds |
| 02/10/2011 | WO2011017125A1 Trisubstituted boron-containing molecules |
| 02/10/2011 | WO2011017122A1 Methods for treatment of pain |
| 02/10/2011 | WO2011017108A2 Cyclopropyl modulators of p2y12 receptor |
| 02/10/2011 | WO2011017096A2 Methods of treating hematologic cancers |
| 02/10/2011 | WO2011017079A1 Process for the preparation and purification of etravirine and intermediates thereof |
| 02/10/2011 | WO2011017054A2 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 02/10/2011 | WO2011017009A1 Novel azaheterocyclic compounds |
| 02/10/2011 | WO2011016952A1 Compositions and methods for treating cancer |
| 02/10/2011 | WO2011016863A2 Methods and uses of cytochrome p450 inhibitors |
| 02/10/2011 | WO2011016814A1 5α-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR |
| 02/10/2011 | WO2011016811A1 Methods for reducing the incidence of chemotherapy - induced mucositis |
| 02/10/2011 | WO2011016799A1 Methods of treating autism spectrum disorders and compositions for same |
| 02/10/2011 | WO2011016749A1 Combined anti-tuberculosis composition |
| 02/10/2011 | WO2011016686A2 Prasugrel disulfonate or crystalline forms thereof, method for preparing same, and pharmaceutical composition containing same |